Core Insights - Movano Health is preparing for the restock of the Evie Ring on September 17, 2024, and has announced a brand partnership with digital creator Heidi D'Amelio [1] - The company is focused on launching the EvieMED and securing B2B opportunities, including obtaining FDA 510(k) clearance [1][2] - Movano Health reported an operating loss of 6.4millioninQ22024,animprovementfromalossof7.4 million in Q2 2023 [3] Business Initiatives - The company successfully closed a 24.1millionprivateplacementinApril2024,whichincludedinvestmentsfromatier−onemulti−billiondollarmedicaldevicecompany[2]−MovanoHealthisadvancingclinicalstudiesforcufflessbloodpressureandnoninvasiveglucosemonitoringusingitsproprietarySystem−on−a−Chip(SoC)technology[1][2]−Thecompanyisintheagreementphasewithaglobalpharmaceuticalcompanyforapotentialprogramstartinginlate2024,withfurtherevaluationsplannedforEvieMED[2]FinancialPerformance−InQ22024,MovanoHealthshipped1,837EvieRingsbutdidnotreportrevenueduetocustomerrefundsoffsettingpreviouslydeferredrevenue[3]−TotalcashandcashequivalentsasofJune30,2024,were16.9 million, an increase from 6.1millionattheendof2023[3][6]−Thecompanyreportedanetlossof6.19 million for Q2 2024, compared to a net loss of $7.27 million in Q2 2023 [7]